ProKidney
PROK
71 hedge funds and large institutions have $220M invested in ProKidney in 2021 Q2 according to their latest regulatory filings, with 71 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$17.7M |
| 2 |
Millennium Management
New York
|
+$15.9M |
| 3 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$12.6M |
| 4 |
KC
Kepos Capital
New York
|
+$11.1M |
| 5 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$11.1M |
Top Sellers
PROK Hedge Fund Activity: Q2 2021 in Review
71 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q2 2021, worth a combined $220M.
Buyers outnumbered sellers: 71 funds opened new PROK positions and 0 closed out — a net gain of 71 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $17.7M.
- 71 institutional investors held ProKidney (PROK) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $220M of ProKidney stock for Q2 2021.
- 71 funds opened new ProKidney positions in Q2 2021 and 0 closed out, a net change of +71 holders.
- The largest ProKidney buyer in Q2 2021 was Adage Capital Partners, an estimated $17.7M added.
Based on aggregated 13F filings for Q2 2021.